UK markets closed
  • NIKKEI 225

    +19.77 (+0.07%)

    +229.85 (+1.05%)

    -2.15 (-2.73%)

    -4.00 (-0.21%)
  • DOW

    -316.56 (-0.93%)

    -143.92 (-0.76%)
  • CMC Crypto 200

    +279.19 (+115.05%)
  • ^IXIC

    +4.71 (+0.04%)
  • ^FTAS

    -2.87 (-0.07%)

$7 Billion Worldwide Cough Syrup Industry to 2027 - Featuring Acella Pharmaceuticals, Bayer, GlaxoSmithKline, Johnson & Johnson and Pfizer Among Others

Company Logo
Company Logo

Global Cough Syrup Market

Global Cough Syrup Market
Global Cough Syrup Market

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Cough Syrup Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to's offering.

The global cough syrup market size reached US$ 5.4 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 7 Billion by 2027, exhibiting a CAGR of 4.42% during 2021-2027.

Report Attribute


No. of Pages


Forecast Period

2021 - 2027

Estimated Market Value (USD) in 2021

$5.4 Billion

Forecasted Market Value (USD) by 2027

$7 Billion

Compound Annual Growth Rate


Regions Covered


Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cough syrup is a combination drug that is used to provide temporary relief from cough, common cold, hay fever and other respiratory allergies. It is manufactured using non-opioid cough suppressants, expectorants and antihistamine compounds to block the symptoms.

The suppressants aid in alleviating the symptoms of dry cough by minimizing the activity of the cough reflex and reducing the urge to cough. The expectorants aid in treating cough with mucus by loosening the mucus, thereby making it easier to expel from the body.

The antihistamines are used to relieve cough caused by minor throat or airway irritation. Cough syrups are usually prescribed by doctors or are available over-the-counter (OTC) in pharmacy stores in a wide variety of flavors, such as cherry, orange, honey and bubblegum.

Cough Syrup Market Trends:

The increasing prevalence of upper respiratory tract infection (URTI) and other respiratory disorders across the globe is one of the key factors driving the growth of the market.

Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the market growth. Cough syrup is primarily used for the treatment of dry cough developed due to the prolonged exposure to poor air quality, tobacco and indoor smoke and air pollution.

In line with this, the rising health consciousness among the masses and convenient product availability in pharmacies and general stores are also contributing to the growth of the market.

Additionally, various product innovations, such as the development of cough syrups with minimal side effects, are acting as other growth-inducing factors. Product manufacturers are developing variants fortified with natural herbs and ingredients with immunity-boosting effects.

Other factors, including rising expenditure capacities of the consumers, along with significant growth in the pharmaceutical industry, are anticipated to drive the market toward growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Acella Pharmaceuticals LLC, Bayer AG, GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Prestige Consumer Healthcare Inc., Reckitt Benckiser Group PLC, Sanofi, Sun Pharmaceutical Industries Limited and The Procter & Gamble Company.

Key Questions Answered in This Report:

  • How has the global cough syrup market performed so far and how will it perform in the coming years?

  • What has been the impact of COVID-19 on the global cough syrup market?

  • What are the key regional markets?

  • What is the breakup of the market based on the product type?

  • What is the breakup of the market based on the age group?

  • What is the breakup of the market based on the distribution channel?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the industry?

  • What is the structure of the global cough syrup market and who are the key players?

  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Cough Syrup Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product Type
6.1 Expectorants
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cough Suppressants/Antitussives
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Combination Medications
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Age Group
7.1 Pediatric
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Adult
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Distribution Channel
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Pharmacy
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Acella Pharmaceuticals LLC Company Overview Product Portfolio
14.3.2 Bayer AG Company Overview Product Portfolio Financials
14.3.3 GlaxoSmithKline PLC Company Overview Product Portfolio Financials SWOT Analysis
14.3.4 Johnson & Johnson Company Overview Product Portfolio Financials SWOT Analysis
14.3.5 Pfizer Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.6 Prestige Consumer Healthcare Inc. Company Overview Product Portfolio Financials SWOT Analysis
14.3.7 Reckitt Benckiser Group PLC Company Overview Product Portfolio Financials SWOT Analysis
14.3.8 Sanofi Company Overview Product Portfolio Financials SWOT Analysis
14.3.9 Sun Pharmaceutical Industries Limited Company Overview Product Portfolio Financials SWOT Analysis
14.3.10 The Procter & Gamble Company Company Overview Product Portfolio Financials SWOT Analysis

For more information about this report visit


CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900